BTMD Stock Analysis: Buy, Sell, or Hold?
BTMD - Biote Corp. Class A Common Stock
$1.41
0.11 (8.46%)
▲
5d:
-4.08%
30d:
-32.86%
90d:
-47.39%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 06, 2026
Get Alerted When BTMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BTMD trading at deep discount. Market pricing in -6.3% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: BTMD trading at deep discount. Market pricing in -6.3% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.87
Based on 12.7% avg growth
INTRINSIC VALUE TODAY
$1.78
21.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BTMD is currently trading at $1.41, which is considered slightly low relative to its 30-day fair value range of $1.40 to $2.03. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.3) compared to its historical average (2.8). Remarkably, the market is currently pricing in an annual earnings decline of 6.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BTMD is in a strong downtrend. Immediate support is located at $1.27, while resistance sits at $1.69. The stock is showing strong short-term momentum, up 8.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.17 (+144.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BTMD is in a strong downtrend. Immediate support is located at $1.27, while resistance sits at $1.69. The stock is showing strong short-term momentum, up 8.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.17 (+144.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.40 -
$2.03
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
84.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+8.5%)
- BULLISH: Trading 144.2% below Wall St target ($3.17)
Fair Price Analysis
30-Day Fair Range
$1.40 -
$2.03
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.27
Resistance Level
$1.69
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.28
Wall Street Target
$3.17
(+144.2%)
Revenue Growth (YoY)
-6.9%
Earnings Growth (YoY)
-36.7%
Profit Margin
14.1%
Valuation Discount vs History
-6.3% cheaper
PE vs Historical
2.3 vs 2.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.3%
(market-implied from PE analysis)
1-Year Target
$1.22
(-6%)
2-Year Target
$1.14
(-12%)
3-Year Target
$1.07
(-18%)
3-Yr Target (if PE normalizes)
(PE: 2→3)
$1.31
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 21.3%)
$22.72
(+1648%)
Base:
(SPY PE: 2.3, Growth: 21.3%)
$2.32
(+78%)
Bear:
(PE: 1.9, Growth: 21.3%)
$1.97
(+52%)
📈
Valuation based on Current Earnings
Trailing PE: 2.07 | Current EPS (TTM): $0.74
Bull Case
$1.30
(-19%)
Analyst growth -23.0%, PE expands to 2.3
Base Case
$1.18
(-26%)
Market implied -23.0%, PE stable at 2.1
Bear Case
$1.04
(-35%)
Severe decline -20.0%, PE contracts to 1.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.3 to 2.8
Stabilization Target:
$1.60
(+22.8%)
PE Expansion Potential:
+22.8%
Share & Embed Analysis
Last updated: March 31, 2026 9:59 AM ET
Data refreshes hourly during market hours. Next update: 10:59 AM
Data refreshes hourly during market hours. Next update: 10:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 62 BUY |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 64 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 48 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$140 | 54 HOLD |
